Oral Mucositis Therapeutics Pipeline to Witness Many Technological Advancements in the Coming Years – P&S Market Research

Oral Mucositis currently exhibits a pipeline with 18 drug candidates.

September 4, 2017 /MarketersMedia/ —

According to a new research report “Oral Mucositis Therapeutics Pipeline Analysis, 2017 – Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments” published by P&S Market Research, Oral Mucositis currently exhibits a pipeline with 18 drug candidates.

The study analyzed that the oral mucositis therapeutics pipeline comprises approximately 18 drug candidates in different stages of development. Oral mucositis is the most common complication of chemotherapy in cancer patients. It causes damage to mucosal lining of the mouth which results in formation of ulcers. It can result in several problems that includes severe pain in mouth, nutritional problems as a result of inability to eat and increased risk of infection due to open sores in the mucosa.

Access Report Overview: https://www.psmarketresearch.com/market-analysis/oral-mucositis-therapeutics-pipeline-analysis

Oragenics, Inc. is using ActoBiotics technology platform for the development of their drug candidates for the treatment of oral mucositis. The technology platform produces a new class of orally delivered biopharmaceuticals. Through ActoBiotics technology platform, food-grade microbes are engineered to generate biologically contained ActoBiotics therapeutics for in situ expression and secretion of novel proteins and peptides including cytokines, enzymes, hormones and monoclonal antibodies within the body.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/oral-mucositis-therapeutics-pipeline-analysis/report-sample

Some of the other key players developing drugs for the treatment of oral mucositis include Daewoong Pharmaceutical Co., Ltd., Cellceutix Corporation, Soligenix, Inc. and others.

Contact Info:
Name: Abhishek
Email: enquiry@psmarketresearch.com
Organization: P&S Market Research
Address: 347, 5th Ave. #1402, New York City, NY – 10016
Phone: +1-888-778-7886

Source URL: https://marketersmedia.com/oral-mucositis-therapeutics-pipeline-to-witness-many-technological-advancements-in-the-coming-years-ps-market-research/236075

For more information, please visit https://www.psmarketresearch.com

Source: MarketersMedia

Release ID: 236075